Protein Kinase, DNA-Activated, Catalytic Polypeptide (PRKDC) antibody
| Antigen | Protein Kinase, DNA-Activated, Catalytic Polypeptide (PRKDC) |
| Synonyms | HYRC, p350, DNAPK, DNPK1, HYRC1, XRCC7, DNA-PKcs, prkdc-A, dna-pkcs, PRKDC, DNA-PKCS |
| Clonality | Monoclonal (3H6) |
| Host |
Alternatives Mouse |
| Reactivity |
Alternatives Human |
| Conjugate |
Alternatives Un-conjugated |
| Application |
Alternatives ELISA, Immunofluorescence (IF), Immunohistochemistry (IHC), Western Blotting (WB) |
![]() |
2 references available |
| Catalog no. | ABIN969366 |
| Quantity | 0.1ml |
| Price | 396.00 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 3 to 4 Business Days |
Additional Information
| Alternative name | PRKDC |
| Gene ID | 5591 |
| Immunogen | Purified recombinant fragment of human PRKDC expressed in E. Coli. |
| Format | Liquid |
| Isotype | IgG1 |
| Clone | 3H6 |
| Description |
The PRKDC gene encodes the catalytic subunit of a nuclear DNA-dependent serine/threonine protein kinase (DNA-PK). The second component is the autoimmune antigen Ku (MIM 152690), which is encoded by the G22P1 gene on chromosome 22q. On its own, the catalytic subunit of DNA-PK is inactive and relies on the G22P1 component to direct it to the DNA and trigger its kinase activity. PRKDC must be bound to DNA to express its catalytic properties. Synonyms: HYRC, p350, DNAPK, DNPK1, HYRC1, XRCC7, DNA-PKcs, PRKDC |
| Molecular Weight | 46.9kDa |
Application Details
| Application Notes |
Western Blotting: 1/500 - 1/2000. Immunohistochemistry: 1/200 - 1/1000. Immunofluorescence: 1/200 - 1/1000. ELISA: Propose dilution 1/10000. Not yet tested in other applications. Determining optimal working dilutions by titration test. |
| Purification | Ascites |
| Buffer | Ascitic fluid containing 0.03% sodium azide. |
| Preservative | 0.03% sodium azide |
| Storage | Store at 4℃, for long term storage, store at -20℃. |
| Restrictions | For Research Use only |
Publications
| Product |
Huston, Lynch, Mohamed et al.: "EPAC and PKA allow cAMP dual control over DNA-PK nuclear translocation." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 35, pp. 12791-6, 2008 (PubMed).
Durkin, Guo, Fryrear et al.: "HTLV-1 Tax oncoprotein subverts the cellular DNA damage response via binding to DNA-dependent protein kinase." in: The Journal of biological chemistry, Vol. 283, Issue 52, pp. 36311-20, 2008 (PubMed). |
Alternatives
Alternatives for antigen "Protein Kinase, DNA-Activated, Catalytic Polypeptide (PRKDC)", type "Antibodies"




Alternatives